Immunity induced by yellow fever vaccination in the elderly (60yrs or older)traveller

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON20831

Enrollment

Registered

2007-08-23

Start date

2007-10-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gele koorts, oudere, reizen, neutraliserende antistoffen, bijwerkingen yellow fever, elderly, travel, neutralizing antibodies, adverse events

Interventions

Yellow fever vaccination (only an extra intervention in control group), blood drawing and urine sampling

Eligibility

Inclusion criteria

Inclusion criteria: Elderly group: 1. Age of 60yrs or older; 2. Indication for yellow fever vaccination according to Dutch travel guidelines Control group: age under 60yrs

Exclusion criteria

Exclusion criteria: 1. Immune suppression due to disease or medication; 2. Pregnancy

Design outcomes

Primary

Measure	Time frame
1. Neutralizing antibodies; 2. Yellow fever viremia	—

Secondary

Measure	Time frame
1. Presence of yellow fever virus proteins in urine samples, 2. adverse events	—

Contacts

Public ContactA.H.E. Roukens

Leiden University Medical Center (LUMC), P.O. Box 9600

a.h.e.roukens@lumc.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)